Predictive Oncology (POAI), a Biotechnology -expected Biotechnology company -driven research -driven by a $ 344.4 million digital asset Treasury centered on Aethir’s Athir token, marked the first time a listed company listed in the Listed in the Listed to the Listed to the Listed to the Listed to the Listed Decentralized physical network listed (DEFIN).
The capital approach was developed with guidance from DNA funds. It is structured as two concurrent private placements on public equity (pipes), combining cash investment with a crypto pipe involving in-kind contributions of ATH tokens, the DNA fund said in a separate announcement.
The structure allows unpredictable oncology to recording tokenized DEPRESSIVE infrastructure as a sheet balance asset, introducing a hybrid financing model that relates to traditional equity markets with decentralized computing networks. ATH’s treasury will be tied directly to Aethir’s decentralized GPU infrastructure.
Aethir is a decentralized cloud network It provides GPU infrastructure for AI, high performance computing and playing applications. The Blockchain technology network uses to coordinate and distribute access to physical compute resources, positioning it as a major participant in the depin market.
The network’s native asset, ATH, is currently trading under $ 0.06 with a market capitalization of nearly $ 2.3 billion, according to CoinMarketCap. The 24 -hour ATH trading volume increased by more than 330%, likely due to the predictable announcement of the oncology treasury.
Related: VC ROUNDUP: Investors will continue to restore Definit, Web3 Gaming, Layer-1 Rwas
Stock’s blockchain blockchain can be predicted
The transfer of oncology to decentralized infrastructure has drawn early attention from investors, with shares that dropped more than 70% on Monday following the announcement of the digital asset Treasury. The rally has pushed the stock to the highest level since March.
Prior to the announcement, unpredictable oncology has spent the last two -year trading as a stock of cent with limited income and a history of quarterly losses. Company reported that only $ 2,682 the income for Second Quarter of 2025 and $ 110,310 to First quarternext to net losses of over $ 2 million per season.
In its latest quarter, unpredictable oncology raises approximately $ 586,000 through a market-offering facility to help fund operations.
In March, the company sold its Skyline Medical Division, which created an automatic liquid management device used in medical centers, as part of a broader approach to cut costs and re -focus on the discovery of AI -driven drugs.
The new oncology approach is positioned in a growing group of small caps and microcap firms talking to Treasury digital asset models. In July, the former Biotech company 180 Life Sciences Rebranded as Ethzilla and announced plans to accumulate ether (Eth) as a Treasury owner.
Other companies that have been exchanged with the public, including Mill City Ventures (MCVT), Nature Miracle (NMHI), UPEXI (UPXI), Helius Medical Technologies (HSDT) and Avax one.
Analysts in Standard Chartered Consistent that Treasury’s digital asset companies may face an appreciation of appreciation as market values of the Net Asset (MNAV), which compares a company’s business value to its crypto handling, continues to decline.
“We see market saturation as the main driver of MNAV’s recent compression,” Standard Chartered wrote, referring to the rapid increase of companies that adopted treasury techniques of digital assets this year.
Related: After the $ 400m splurge, Eth Treasurer Eyes Stock Buyback in the midst of action concerns
